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Abstract
Women are not small men. Sex-specific differences do not only affect the classical target
organs of sexual differentiation and reproduction, but have been found to involve most, if
not all the organs and tissues in the body. One of the consequences of this dimorphism is
that diseases manifest in a sex- and gender-specific way. Key to maintenance of a healthy
state is functioning tissue able to cope with insults. Regulated death of damaged cells and
replacement with new cells by proliferation is a prerequisite for maintaining tissue func-
tion taking place at different pace in the different organs. The intent of this chapter is to
review current evidence for sex-specific differences in tissue homeostasis focusing on the
variability of hormone exposure characteristic for the female reproductive life stages.
Keywords: tissue maintenance, sex differences, proliferation, cell death, kidney, menstrual
cycle
1. Introduction
Living systems are continuously challenged by potentially toxic internal and external pro-
cesses. The normal metabolic function of the cells produces a plethora of potentially damaging
oxidative metabolites inducing damage in DNA, proteins, and lipids. In addition, living cells
are exposed to a variety of external factors, which may be internalized as building blocks and/
or energy sources. These vital processes put the organism at risk to be harmed. Coping
strategies are necessary to avoid damage. There are several lines of cellular defenses induced
via cell stress pathways, including compartmentalization processes, enzymatic modification,
externalization, degradation, and repair [1, 2].
Ultimately, these processes may not be sufficient to prevent major cellular damage. Therefore,
every cell is in addition equipped with internal cell death programs, which can be activated in
order to prevent a damaged cell to cause harm to the organism [3]. Cell losses are inevitable
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and take place continuously in our bodies even without a specific trigger. The rate of cell death
may be significantly enhanced at times of increased challenges. Cellular losses are necessary in
order to prevent detrimental effects like neoplastic transformation [4]. Thus, programmed cell
death needs to be carefully balanced, and this ability is a key determinant for the health and
survival of the organism.
Cells lost by cell death need to be replaced in order to maintain cell numbers and ultimately
tissue function. Controlled regeneration is, thus, required to cope for cell losses due to toxic
challenges derived from internal and external sources, be they derived from normal metabolic
processes or damaging environmental stimuli. Cell losses and proliferation need to be carefully
balanced in order to guarantee proper function. Thus, the process of tissue homeostasis, that is,
the capability to send damaged cells into cell death programs, to replace the cells by prolifera-
tion, and to regulate the exact balance of these events are crucial processes for preserving a
healthy state. Any distortion of the balance between cell death and cell proliferation—be it by
overwhelming damaging events beyond the host’s range of tolerance and/or primarily ineffec-
tive or maladaptive homeostatic mechanisms by the host—is prone to induce malfunctioning
of the organs in the body ultimately causing disease and potentially death.
2. Sex and sex hormones in tissue homeostasis
2.1. Origin of sex differences
During development, sex differences originate from genetic and hormonal influences. Master
regulators for male sex differentiation, like SRY, are encoded by DNA of the Y chromosome
governing the embryonic development of the male phenotype in mammals. Female or male
gonadal development gives rise to a sex-specific hormonal environment [5]. Sex hormones
induce organizational effects during the life span causing persistent sex-specific changes
within the tissues, for example, by epigenetic modifications [6, 7]. Activational effects further
introduce sex differences in tissue structure and function depending on the pattern of exposure
to gonadal hormones. All the organs in the body are affected throughout life [8]. In this respect,
sex differences are based on the different chromosomal equipment that qualifies every cell in
the body as male or female. These basic differences are further shaped by sex hormones
depending on previous or current, transient or persistent exposure [9]. This hypothesis was
phrased by Arnold [10] as follows: “XX and XY cells are different prior to the secretion of
gonadal hormones, and gonadal hormones affect XX and XY cells unequally.”
Sex hormones act through receptors widely expressed throughout the cells of the body. The
classical estrogen (ERα, ERβ), androgen (AR) and progesterone (PR) receptors belong to the
nuclear receptor protein family acting through the nucleus as transcription factor or co-factor. In
addition to their nuclear actions, they were found to be localized to the cell membrane and
mitochondria inducing fast, non-genomic intracellular signaling pathways, for example, by the
interaction with growth factor or cytokine receptors. Estrogen-binding cell membrane-localized
receptors of the seven transmembrane receptor family were also characterized, for example,
G-protein coupled estrogen receptor, GPR30/GPER-1 [11–13].
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Ultimately, differences between the sexes derive from chromosomal and hormonal sex differ-
ences, which are further influenced by environmental factors. Thus, differences originating
from the biological sex are further shaped by gender, which refers to the perceptions of male or
female identity and depends on sex-based social structures [8].
2.2. Influence of sex and sex hormones on cellular proliferation
Tissue homeostasis is guaranteed, when cells lost in physiological tissue turnover or under
stress conditions are replaced by proliferation. Organs with high demanding functions have
increased regeneration potential and continually renew their cell populations. This is the case
for intestine, skin, and blood, for example. Liver, bone, and blood even have the capacity to
fully recover to the original size after loss of tissue [14]. Other organs have lower regeneration
potential, like the heart, brain, and kidney [15–17]. Many organs contain stem cell niches
hosting adult tissue stem cells that are precursor cells maintained in a relatively undiffer-
entiated state ready to replace lost cells by proliferation followed by differentiation [18, 19].
Sex hormones have classically been implicated in regulation of proliferation of cells of reproduc-
tive organs and cancer of reproductive tissue [20–24]. Besides these effects, sex hormones were
also found to have pronounced effects on the proliferation of different stem cell populations. Cell
proliferation of embryonic stem (ES) cells was found to be enhanced by female gonadal hor-
mones [25]. ES cells are derived from the inner cell mass of the embryoid body. They can self-
renew in vitro and are pluripotent, that is, they can differentiate into all the cell types of the body
[26]. Estrogen appears to act via nuclear and cell surface signaling pathways involving Erk1/2
activation, cyclin-dependent kinases and proto-oncogenes like c-myc, c-fos, c-jun, and pRB in ES
cells. In addition, store-operated calcium channels were found to play a role in estrogen-
mediated cell proliferation through the transcription factor NF-AT [27].
Differentiation of ES cells into dopaminergic neurons was also shown to be affected by estro-
gen. ERβ promoted differentiation by crosstalk signaling with insulin like growth factor-1 [28].
Motor neuron differentiation from ES cells was found to be enhanced by 17-β estradiol and
progesterone through nuclear ERα and progesterone receptor [29]. Dopaminergic precursors
derived from ES cells were found to increase proliferation upon treatment with progesterone
in vitro [30].
Induced pluripotent stem (iPS) cells are similar to ES cells with regard to their ability to
differentiate into all cell types, providing a promising tool for in vitro research and regenera-
tive medicine. They are derived from adult mature cells by reprogramming through the
introduction of specific transcription factors [31]. Similar to ES cells, sex hormones were shown
to affect iPS cells. Neuronal cells derived by differentiation of iPS cells showed increased
dendritic branching by treatment with 17-β estradiol [32]. Functional integration of dopami-
nergic neuronal cells from iPS cells into neuronal circuits was found to be enhanced by
estradiol [33]. Testosterone was described to enhance differentiation of iPS cells into insulin-
producing cells [34].
Sex differences were also described for tissue stem cells in vivo. Adult stem cells are believed to
provide a local pool of self-renewing, multipotent cells pivotal in tissue homeostasis and
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recovery upon damage [35]. Stem cells in many stem cell niches appear to have a higher ability
to self-renew, have an increased regeneration potential, and in some cases, show higher
proliferative activity in women [36, 37]. Intrinsic sexual dimorphism was described for neural
stem cells that hold much promise for potential brain damage repair therapy in the future.
Proliferation of neural stem cell was, for example, shown to depend on hormone changes in
the adult mouse due to the estrous cycle, pregnancy, reproductive status, and age. Phases of
high estrogen exposure like pro-estrus were found to be associated with increased hippocam-
pal adult neurogenesis indicating a role of estrogens [38]. Differential expression of sex steroid
receptors and androgen metabolizing enzymes may result in differential outcomes in neural
stem cell transplantation [39]. Neural stem cell proliferation was found to be dependent on
nuclear ERs, while oligodendroglial differentiation was stimulated by cell membrane-associated
ERs [40]. Other researcher also proposed that actions of sex steroids on the brain might be
correlated with reduced brain damage. Intact females were found to be less susceptible upon
injury than ovariectomized females and males [41]. Similarly, muscle-derived stem cells derived
from female mice and transplanted into dystrophic mutant mice showed a better potential to
regenerate skeletal muscle than stem cells from males [42].
Hematopoietic stem cells were found to be more abundant and proliferative in female mice in
comparison to males dependent on estrogen exposure [43]. 17-β estradiol was found to
improve hematopoietic differentiation from human iPS cells and from human umbilical cord
blood through ERα signaling suggesting a universal function for estrogen in hematopoietic
stem cell differentiation [44, 45].
Estrogens have beneficial effects on bone regeneration [46]. Osteoblasts are stimulated by
estrogen to proliferate with distinct roles for ERα and ERβ [47]. In vitro, proliferation of bone
marrow mesenchymal stromal cells was found to be enhanced by estrogen [48]. Estrogens
enhanced the proliferation and migration of bone marrow-derived endothelial progenitor cells
to ischemic regions of the heart facilitating repair and regeneration [49]. Androgens were also
described to stimulate the proliferation and angiogenesis/vascular repair capability of circulat-
ing endothelial progenitor cells in males, not females [50].
2.3. Sex differences in cell survival
When progenitor cells involved in tissue regeneration enter a cell senescence state, tissue
homeostasis may be compromised. The cells are able to permanently halt the cell cycle and
persist in a quiescent, but still functional state [51]. This is a possible fate of cells damaged
beyond repair. The three major types of senescence are replicative senescence, oncogene-
induced senescence, and DNA damage-induced DNA damage. The DNA damage response
pathway appears to be eventually involved in the execution of the program independent of the
primary stimulus [52]. Furthermore, senescent cells are able to influence their neighboring cells
by secretion of a range of activating signals referred to as senescence-associated secretory
phenotype. The signals may favor a pro-inflammatory or—alternatively—an immunosup-
pressive/pro-fibrotic state. Both phases appear to be important for successful tissue repair and
the timing of the shift in the secretome might be crucial [53]. The etiology and progression of
Homeostasis - An Integrated Vision32
many cancerous or age-related diseases have been shown to be influenced by the secretome of
senescence cells [54–56].
Alternatively, cells may activate a cell death program as a means to ensure physiological tissue
renewal or in response to overwhelming damage. The most common are type I cell death
programs or apoptosis, type II or autophagy, type III or necrosis, and mitotic catastrophe [57,
58]. The cell death modalities are characterized by different morphological criteria and are
executed by specific intracellular signaling cascades. Specific catabolic enzymes are typically
associated with specific forms of cell death, for example, caspases with apoptosis. The path-
ways are interdependent. The intensity of the damage signal is often decisive for the type of
cell death program that is executed or the switch from one modality to the other. In addition,
autophagy is not primarily regarded as a cell death mechanism. Autophagy describes a
process involving the break-down and recycling of specific subcellular organelles. This process
may provide a cell survival strategy by reducing damaged organelles and/or shifting internal
resources in order to optimize cell survival. Only if the damaging process exceeds the cellular
defenses, cells die in the process [59, 60].
Regarding the role of sex in cell fate decisions, several reports have highlighted distinct sex-
dependent differences. Sex hormones have been shown to influence the propensity of cells to
undergo apoptosis. In general, lower concentrations of estrogen were found to be protective,
while higher concentrations were found to promote apoptosis. Androgens were found to
enhance, but also to suppress apoptosis depending on the cellular context [61, 62]. For exam-
ple, estrogen and testosterone were described to reduce apoptosis in skeletal muscle cells [63].
Both hormones also appear to prevent apoptosis in neuronal cells adding to their
neuroprotective function [64, 65]. An anti-apoptotic action of testosterone was also described
in pancreatic β cells from male rats, but not from female rats [66]. Estrogen and estrogenic
compounds, however, appeared to enhance apoptosis in pancreatic β cells in elderly mice,
while it reduced apoptosis in young animals [67]. Regarding vascular endothelial cells, several
studies have shown that estrogens protect from apoptotic cell death [68, 69], while apoptosis
increased in coronary artery endothelia from postmenopausal women [70]. Testosterone was
found to induce apoptosis in endothelial cells [71–73]. Treatment with testosterone also
induced apoptosis or senescence in human dermal papilla cells, a process implied in inherited
male alopecia [74, 75]. In addition, androgens were found to promote apoptosis in renal and
intestinal cell lines and bone marrow-derived macrophages [76–78].
Overall, sex hormones appear to influence cell fate decisions depending on the cell context.
Hormone independent sex differences are also apparent shaping the cellular response [79].
Thus, female and male cells appear to rely on different coping strategies in response to
stressors. For example, vascular smooth muscle cells isolated from aorta of male rats appear
to be more inclined to undergo apoptosis in response to UV irradiation, while female cells are
more prone to execute the cell senescence program [62, 80]. Female cells showed characteristics
of autophagy, which is presumed to help female cells to repair the UV-induced intracellular
damages ultimately providing a survival strategy [81]. In addition, female cells were found to
better adhere to the growth support, thus avoiding apoptotic cell death initiation by cell
detachment, a process called anoikis-resistance. Differences in the intracellular organization
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of the actin cytoskeleton and increased phosphorylation of focal adhesion kinase were attrib-
uted to this higher propensity of female cells to adhere [81]. Apparently, female cells are better
equipped to prevent cell death. While autophagic processes were found to protect neuronal
cells from cell death due to starving in female rats, male cells were not able to benefit and died
more often from autophagic cell death [82]. Organ-specific sex differences were found in
constitutive autophagy, a process implicated in physiological tissue turnover. While
autophagic marker proteins were increased in the male versus female heart and liver, no such
differences were observed in the kidneys [83]. Osteoblasts showed reduced autophagy in aging
female mice, while the rate remained constant in males over the life span. This was correlated
with higher oxidative stress in female cells, thus potentially enhancing bone loss and playing a
role in the pathophysiology of osteoporosis in women [84]. Estrogens alter the redox balance and
counteract bone loss [46]. Stem cells involved in generation of osteoblast, namely bone marrow
derived mesenchymal stem cells, were found to be influenced by estrogens not only inducing
increased proliferation, but also reducing senescence and apoptosis [85].
In general, increased antioxidative cellular defenses were implicated to provide females with
better strategies to cope with oxidative stress and prevent cellular losses [62]. Differences in
basal redox state and responses to oxidative imbalance were demonstrated between female
and male cells [86]. For example, female cells were shown to produce less hydrogen peroxide
and superoxide anion. Anti-oxidative enzymes, such as superoxide dismutase (SOD) and
catalase, showed higher basic activity in female versus male cells [87]. Thioredoxin reductases
and manganese SOD were increased by estrogen in cardiomyocytes [88, 89]. In vascular
smooth muscle cells and circulating monocytes, estrogen was found to stimulate manganese
and extracellular SOD expression [90]. Estrogen was, furthermore, shown to modulate the
expression of other key molecular defense enzymes differently in XX and XY cells, for exam-
ple, poly-ADP ribose polymerase (PARP), a DNA damage repair enzyme, or RLIP76, a cell-
protective transporter protein [86].
PARP was also found to play a major role in sex differences in stroke. Experiments in mice
have shown that ischemic neuronal cell death is dependent on intact neuronal nitric oxide
synthase (nNOS)/PARP signaling, while in females a protection is provided by estrogen
paradoxically also requiring an intact nNOS/PAPR axis [91]. While male neuronal cells appear
to die via a PARP-mediated caspase independent pathway, ischemic cell death pathways
appear to be dependent on activation of caspase-dependent cell death pathways in females
[9, 92]. Such sex-specific differences may be relevant for the sex-specific difference in stroke
prevalence [93, 94].
PARP signaling was also implied in sex differences in cell fate decisions in kidney cells. In a
mouse model of immune-mediated nephritis, PARP signaling induced necrosis in male cells
and inhibition of PARP shifted the pro-inflammatory necrotic cell death to an anti-
inflammatory apoptotic pathway. In female cells, by contrast, cell death was independent of
PARP and female cells preferentially underwent apoptosis. Estrogen acted in a pro-survival
manner in female cells only. In addition to the kidney cells, bone marrow-derived hematopoi-
etic cells showed similar sex differences [95].
Mitochondria play a crucial role in apoptotic cell death programs. Estrogens were described to
modulate the propensity for mitochondrial initiation of apoptosis [61, 96]. Estrogen-mediated
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modulation of mitochondrial function is achieved by hormone effects on the expression of
mitochondrial and nuclear genome-encoded mitochondrial proteins [97–101]. Since mitochon-
dria are central in the cellular defense against oxidative stress, mitochondria are especially
sensitive to accumulate damage over time. Malfunctioning mitochondria accumulate during
aging, a process regarded as a major contributor to the onset of many age-related diseases [102,
103]. Sex differences were observed in this process. Delayed malfunctioning of mitochondria
during the aging process might provide females with better strategies to cope with cellular
stressors. Maternal transmission of mitochondria appears to provide a more favorable envi-
ronment in female offspring [104]. Xist, an RNA-coding gene involved in X chromosome
inactivation in female cells, appears to be pivotal for mitochondrial maintenance [105]. Mito-
chondrial biogenesis and degradation by mitophagy are dependent on the transcription factors
p53 and FOXO [106, 107]. Sex-specific differences in the activity of these nuclear factors were
reported. Males were shown to exhibit relatively greater FOXO activity. Females, on the other
hand, had higher p53 activity resulting in sex-specific differences in the ability to maintain
healthy mitochondrial functionality during aging [105].
2.4. Potential consequences of sex-specific differences in tissue homeostasis
The abovementioned paragraphs have described examples of sex-specific differences regard-
ing processes involved in tissue maintenance, like the control of cell proliferation and cell
death. Such effects may ultimately result in differences in the ability of female and male tissues
to cope with stressors affecting the ability to repair and restore function or develop disease.
Many diseases show different incidence and prevalence rates in men and women derived from
sex and gender specific pathophysiological mechanisms. Sex and gender differences have been
studied intensively in the neural system, the cardiovascular system, and the development of
cancer, among others [108–110].
Mechanisms underlying differences in kidney diseases between men and women are less well
known, despite renal diseases with a high morbidity and mortality risk being a challenging
problem for patients, clinicians and society [111, 112]. International registries show that fewer
women than men develop kidney failure [113–116]. The underlying causes, however, are
widely unknown. The presumed female protective effects appear to be most pronounced in
women of reproductive age [117–120]. This finding suggests that female sex hormones might
play a key role. Estrogen was proposed to be renoprotective via modulating renal perfusion
and effects on the vasculature. Furthermore, a role of estrogen was proposed in the control of
the local renal renin-angiotensin system [121–123]. On the other hand, estrogen was implicated
in the control of mesangial and tubular cell proliferation and linked to neoplastic transforma-
tion of the kidney in hamster kidneys. Low estrogen concentrations were shown to induce
proliferation in glomerular mesangial cell, while high concentrations suppressed it [124].
Primary proximal tubular cell explants and subcultured dissociated proximal tubular cells
were shown to proliferate, when treated with estrogen at physiologic concentrations [125].
This finding was confirmed in primary rabbit proximal tubular cells, which showed increased
proliferation upon estrogen treatment [126].
We have previously shown that renal tubular cell-specific proteins appear at higher rates in the
urine of healthy women at specific hormonal transition phases of the natural ovulating
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menstrual cycle. Urinary samples from healthy probands showed increased rates of urinary
excretion of the marker proteins Fructose-1,6-bisphosphatase and Glutathione-S-transferase α,
when estrogen levels decreased after a preceding height associated with ovulation and luteal
phase [127]. Both enzymes are specifically found in proximal tubular cells, the most populous
cell type in the kidney. When proximal tubular cells are damaged, intracellular enzymes are
released into the urine, making them clinical markers for kidney injury. In contrast to ovulating
women, male probands and postmenopausal women showed consistently low levels of these
renal marker proteins over time. Other urinary proteins, for example, albumin, α1-
microglobulin, and immunglobulin G, which are markers for functional changes of the glo-
merular filter and/or tubular protein resorption, showed constant urinary excretion suggesting
that the observed increases of proximal tubular marker protein release in ovulating women are
not accompanied by major functional distress of the kidneys [127]. This pattern of urinary
marker proteins excretion suggests that cyclical changes of female hormones might affect
kidney cell health. Tubular enzymes are released into the urine, if proximal tubular cells are
sloughed off and/or their plasma membranes become leaky. This could be due to tubular cells
being transiently more prone to damage in situ resulting in plasma membrane leakage or to
the cells being removed from the tubular epithelium and released into the urinary space, for
example, by apoptosis. Both processes lead to increased cell losses. Tissue homeostasis would
be maintained, if increased cell removal was accompanied by increased cell proliferation. This
could be the case during the high estrogen exposure phases preceding the observed tubular
enzyme releases into the urine. The finding that tubular cells are able to proliferate upon
estrogen treatment [126] is in line with this hypothesis. Such a periodic interplay between cell
proliferation and cell loss brought about by the specific changes in the pattern of sex hormone
exposure might result in an increased rate of tissue renewal. If this was the case, then women
in their reproductive years would possess an efficient means to easily get rid of potentially
injured, dysfunctional or simply older proximal tubular cells by replacing them with fresh new
cells. Such a transiently increased repair capacity might provide an efficient means to cyclically
renew renal tubular tissue leading to a higher resistance to damage. It is, however, also
possible that during the short phases of increased tubular cell death, the kidneys might be
especially sensitive to damage. With regard to the potential beneficial action of treatment of
renal proximal tubular cells with a proliferation-inducing growth factor, we have previously
demonstrated that epidermal growth factor (EGF) treatment was able to accelerate tissue
repair after treatment with interferon α (IFNα) in vitro. However, if EGF was present before
or during IFNα treatment, epithelial barrier destabilization was intensified [128, 129]. There-
fore, the overall effect might be different in other cycle contexts or under hormone therapy, if
the vulnerable phases might not be restricted to short periods.
3. Conclusion
In conclusion, it appears that males and females are equipped with stress coping strategies that
may differ between the sexes. Sex differences have been demonstrated in the cellular
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expression levels and activity of detoxifying and repair enzymes, in the propensity to use
autophagic processes for repair, in senescence or cell death programs and in the ability to
replace cells by proliferation (Figure 1). These effects are apparent in isolated cells and are
further shaped by exposure to sex hormones. Sex hormone levels cyclically changing in
dependence of the female reproductive hormone cycle might enhance physiological tissue
regeneration and provide greater damage repair potential. Overall, female tissues appear to
be more resistant to cellular stress than their male counterparts.
Acknowledgements
This work was supported by the Austrian Central Bank Fund project No 13671 to J Lechner.
Conflict of interest
The authors confirm that there are no conflicts of interest.
Author details
Judith Lechner* and Gerhard Gstraunthaler
*Address all correspondence to: judith.lechner@i-med.ac.at
Division of Physiology, Medical University of Innsbruck, Innsbruck, Austria
Figure 1. Sex and sex hormone-induced differences in tissue homeostasis. The figure shows strategies involved in tissue
maintenance following cellular stress. Sex differences and sex hormone-dependent effects have been shown in these
processes in different organs and tissues.
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